Latest / "Isn't That Interesting?!": Breast Cancer Survivor Stories + Remarkable Research / Season 2 / Episode 6: Dr. Carrie Hruska
Transcript
- 0:00Like a stealthy enemy, breast cancer has hiding places,
- 0:04especially in areas of dense breast tissue where it can slip
- 0:08past traditional mammograms. But thanks to a Mayo Clinic
- 0:12physicist and a gram from earlier.org, Molecular Breast
- 0:16Imaging can see what mammograms may miss.
- 0:20Here's Martha Kaley, founder and executive directorofearlier.org,
- 0:23with this week's episode of Isn't That Interesting?
- 0:28All right. Hi, everyone.
- 0:30I'm so excited to share with you Doctor Kerry Rushka, Dr. Rushka
- 0:35and I, but I'll probably be calling her Kerry.
- 0:39We met a number of years ago at a meeting and I will always
- 0:44remember because she saw my name tag and I saw her name tag and
- 0:48she said, well, what do you do? And I told her that we raise
- 0:52funds for funding a better method for earlier detection of
- 0:55breast cancer. And she took me by the shoulders
- 0:58and said, come with me. So we went over and she told me
- 1:02all about what she was doing. And then our medical advisory
- 1:05committee afterwards, you know, a couple of years later, I think
- 1:10wasn't it Carrie? And she submitted a grant and,
- 1:14and they chose that grant. And it was just like, oh, yay.
- 1:17So it was really hysterical when we we got together.
- 1:21So I'm just going to tell you that my impression of all of our
- 1:26researchers who we have spoken with and you're one of them,
- 1:30they are such modest people. And because I was looking at
- 1:35your research and the results of that and it is really astounding
- 1:41the impact that they had that it has made.
- 1:44So if you could just tell our audience perhaps a bit about how
- 1:50how you came across this and what you did.
- 1:52And I know you worked with Doctor Deborah Rhodes too.
- 1:55So, so you would don't mind just sharing what our grant did for
- 1:59you of? Course, of course, it's so fun
- 2:02to be with you. I thank you for remembering that
- 2:07meeting. That was many years ago,
- 2:09probably almost 20 years ago, but you can see we, we put your
- 2:14money to good use, I hope. And, and in those early days, I
- 2:19mean, I was, I'm, I am not a clinician, I'm a physicist.
- 2:24So I was very interested in, you know, the camera technology and
- 2:29you know, how we could provide better medical imaging tools.
- 2:33That has kind of been my my career focus.
- 2:36And I had a chance to work on when I was still in Graduate
- 2:40School or right out of Graduate School, work on a project where
- 2:44a researcher, Michael O'Connor, was my physics mentor, was
- 2:48working on a camera that was really designed for cardiac
- 2:52imaging. But he had the idea that maybe
- 2:55you could do breast imaging with it.
- 2:57And so he's a nuclear medicine physicist, so kind of as far
- 3:01away as you can be from the world of breast cancer
- 3:04screening. But we had this friend and
- 3:06colleague, Deborah Rhodes, who you mentioned and she is just a
- 3:10phenomenal clinician and was seeing patients every day in her
- 3:15breast clinic who, you know, unfortunately, even though they
- 3:19had LED healthy lives and done everything right, you know, done
- 3:22the right things and gone for screening faithfully were often
- 3:27presenting with breast cancer and not even early breast
- 3:32cancer, you know, sometimes pretty advanced breast cancer
- 3:35and it just didn't quite makes sense.
- 3:37So she was trying to find an answer to this problem.
- 3:41And, you know, today, I'm sure your listeners are, are familiar
- 3:45with many modalities that we have.
- 3:47And you know, the, the talk about dense breast tissue is
- 3:52very common now commonly known that this can be an issue.
- 3:56But 20 years ago, this was very controversial and we didn't have
- 4:00a lot of answers about what to do and even how big of a problem
- 4:05it was. So just it was kind of an
- 4:09incredible story that we had this little tool we were just
- 4:12kind of playing around with, and it was just this little camera.
- 4:15But there was very old data that showed that in nuclear medicine,
- 4:20sometimes women who were having cardiac scans or scans for other
- 4:24reasons would just kind of accidentally find a breast
- 4:28cancer on those scans. So there was this idea that you
- 4:31could use nuclear medicine scanning to find breast cancer.
- 4:34But the camera technology was so poor.
- 4:37I mean, it had to be a pretty big cancer before you would find
- 4:40it. And that's kind of, you know,
- 4:42it's too late. So with this new camera that has
- 4:45semiconductor technology and very small pixels, which is very
- 4:50common today, but it was at the time we could place the breast
- 4:54right on the camera very similar to what you do with a mammogram.
- 4:58And we were finding lesions that were very small and cancers that
- 5:03were very small and finding them much earlier than you would find
- 5:07on a mammogram, especially in women who have difficult
- 5:10mammograms like a lot of dense tissue or maybe they have
- 5:14scarring from a past surgery or something that would make your
- 5:17mammogram more difficult. So with the with the funding
- 5:20from friends or friends for an earlier breast cancer test, I
- 5:24think you've funded actually several seed grants for our team
- 5:28because nobody really wanted to take a risk on us 'cause we were
- 5:31kind of out there. Thank you for listening to what
- 5:36we had and taking this seriously because we were serious, but we
- 5:40didn't understand how it would work best for women.
- 5:44So there was just this huge, you know, like 10 years of just
- 5:48trying to get the technology right, make it a comfortable
- 5:51exam, do things so that we could lower the radiation dose, which
- 5:55we did and just kind of understand what are the best
- 5:59clinical applications. And in recent years we have come
- 6:04to find that offering. So what this test is called, I
- 6:08should get to the end is molecular breast imaging is what
- 6:12we ended up calling it or MBI. And we at Mayo, Mayo Clinic,
- 6:17where I work in Minnesota, we offer this to women as a
- 6:21supplemental screen. So if you come in and you have
- 6:25dense breast tissue on your regular screening mammogram, you
- 6:29may be offered several other options to kind of take another
- 6:32look or have a supplemental screen.
- 6:34And at Mayo, a lot of women choose MBI.
- 6:37So this has gone from something that was really just kind of a
- 6:41fringe research project to something that is very important
- 6:45in our routine clinical practice.
- 6:48So thank you for taking a risk on us because you were the first
- 6:51people who funded us and it led to many more grants after that
- 6:55and federal grants. And I'm so happy you were able
- 6:58to offer this to women now. Well, I am so delighted and I
- 7:03see you have progressed so much with your information too.
- 7:08Can you identify, you know, one of the things I found
- 7:11interesting is that you're more able to identify lobular breast
- 7:17cancer, which I think is obviously is a really difficult
- 7:21breast cancer to discern. So that one and then what then
- 7:26there are a lot of others that you were talking about that
- 7:29you've been able to do small invasive answers.
- 7:33I just the, the serviceability of this particular instrument is
- 7:39really remarkable. And I think your ability, one
- 7:43thing that just knocks me off my seat is that how much you were
- 7:49able to lower the dosage of the contrast agent.
- 7:52If you would address that, that's that's pretty miraculous.
- 7:56Sure. Thank you for noticing those
- 7:58things. So really the technology is
- 8:01pretty simple. There's two components to it.
- 8:04There's the detector or the camera.
- 8:07And we used research seed money to kind of redesign that camera.
- 8:13And there's several components of the camera that can make it
- 8:16more efficient for collecting radiation.
- 8:18So if you can make better use of that, you don't have to
- 8:22administer as much to the patient.
- 8:24So the other part of that test is the radio tracer.
- 8:28So like several tests for you know like an MRI or a contrast
- 8:33enhanced mammogram. In MBI, we do administer a
- 8:36contrast agent. It is called Technetium 99-M
- 8:40Sestamidi and it's not. Easy for you to say.
- 8:44Yep, and so you could just call it MIDI.
- 8:47That's and MIDI is very common in nuclear medicine and medicine
- 8:52in general because it's used for a lot of cardiac imaging and
- 8:56some other tests as well. But the nice thing about it is
- 8:59it's been around a really long time, you know, since the 90s,
- 9:03it was FDA approved. And it's very safe.
- 9:07Like there's a very, very low risk of having reactions.
- 9:11And it also has a really low radiation burden.
- 9:15It doesn't stick around in the patient very long.
- 9:17It's basically gone within a day.
- 9:20And because we improve the efficiency of the camera, we
- 9:23only have to give a very small amount to get a good enough
- 9:26image. So really the radiation is about
- 9:29the same level as a mammogram now as a 3D mammogram.
- 9:33And even though, you know, some women may even have concerns
- 9:37about radiation, I fully know that it's a safe amount to have
- 9:42on a routine basis. Like you could have this test
- 9:45every year. It's not going to present any
- 9:47risk to you. That wasn't always the case.
- 9:49In early days, we were kind of using the standard amount of
- 9:52radiation and it was kind of a lot and, and more than we want
- 9:56for a screening test. So now it's in a safe range.
- 10:00You mentioned lobular cancer. So the reason why MBI actually
- 10:05works so well is because that tracer, even though it wasn't
- 10:09even designed for breast cancer, it just is sucked up by cells
- 10:13that are rapidly changing and dividing have a lot of it's,
- 10:17it's sequestered in the mitochondria.
- 10:19So if you have a lot of cellular activity, it's going to go there
- 10:23and it's also going to increase if there's more blood flow.
- 10:27So that's why cancers can light up a lot.
- 10:30You can also see some benign things.
- 10:33We do have false positives, but especially lobular cancers that
- 10:36tend to grow more kind of, you know, twisty, they're not, they
- 10:40don't make just like a solid mass.
- 10:42Sometimes that can be more difficult for all modalities to
- 10:46detect. But we have found that MBI can,
- 10:50can sometimes pick those up and pick them up at a higher rate
- 10:53than a mammogram can, especially in dense breast tissue.
- 10:57But in our, so we did I, I think you're familiar with this.
- 11:00We just published a big trial on MBI, which was the first multi
- 11:05center national trial. We had five different sites and
- 11:10this was kind of the our big, this was our big gun because
- 11:14this is the first time that we had compared MBI in a large
- 11:18screening trial to modern day mammography like 3D
- 11:22tomosynthesis. And we screened women for
- 11:25multiple years. We had almost 3000 women
- 11:28participate and we found that in.
- 11:31So all of these women had dense breasts on their mammogram and
- 11:34they had no symptoms, no reason to suspect breast cancer and
- 11:38they weren't even really very high risk.
- 11:40They were kind of intermediate risk, but we found that of the
- 11:44cancers that MBI detected, so MBI detected more than double,
- 11:48so more than twice as many cancers and 70% of those were
- 11:53invasive. So we're finding that because
- 11:57that tracer is going to cancers that are, you know, really
- 12:01active, they it tends to go more to invasive cancers.
- 12:04So those are invasive cancers that were totally missed on the
- 12:08routine screening mammogram. So we were, you know, talk about
- 12:12astounding. Like we were astonished at the
- 12:15rate of cancers that we detected.
- 12:17And sometimes you would think, well, maybe the first time out,
- 12:21you're kind of finding those cancers that have been left
- 12:23behind over years of screening. But we screened them the
- 12:26following year as well. And even at the second year, it
- 12:30continued to find cancers that were being missed on
- 12:33mammography. So we kind of know that from
- 12:36lots of modalities that in dense breasts were missing things.
- 12:40But the to find more than double that was really, it's, it's
- 12:46almost like an injustice to me. It just, it just kind of made me
- 12:50almost angry that we weren't doing better for women.
- 12:53So I'm a strong advocate of seeking some kind of
- 12:56supplemental screening. And I love that because you've
- 13:01opened up so many options for the medical community.
- 13:05When I was reading your work, I was thinking about, so as a
- 13:09physician, when you have that option of monitoring, that's
- 13:15just such a big adjunctive support for rather than just
- 13:21going in, you know, Willy nilly and but to to be able to really
- 13:26monitor that. I think that that is such a
- 13:29wonderful contribution. And I just think that this, this
- 13:33whole process is, is so promising for for women and the
- 13:40fact that you can discern so, so many and take action with that.
- 13:47So it's great work, Gary, y'all have done wonderful things.
- 13:51What's your what's your outlook for now with this?
- 13:56Do you do you see options for it?
- 14:00Right, No, you make a really good point.
- 14:02I'm glad that you brought that up about, you know, options for
- 14:04women, because I think that's our that's always been our
- 14:08thing. I've I've been very careful to
- 14:10not try to get so invested in just developing 1 certain
- 14:14technology, but our goal has really been to give women better
- 14:19options if they have, if on their routine screening is just
- 14:24not good enough. And it used to be very hard to
- 14:28say that because we certainly don't want to discourage women
- 14:31from getting screening mammograms because they do work
- 14:34in many women. They do find breast cancers
- 14:37early in many women. But we know that about half of
- 14:41women in the US have dense breasts.
- 14:44And I've seen with my own eyes how easy it is to miss something
- 14:48in a dense breast. So I'm glad that we're talking
- 14:51about this. And I feel like there used to be
- 14:54kind of a, well, maybe there still is, and I'm just ignoring
- 14:57it. But there used to be almost like
- 14:59a competition over people. You know, you have people who
- 15:02are really like, they're MRI people or they're nuclear
- 15:04medicine people or they're ultrasound people.
- 15:06But I think that's kind of not the point we're missing.
- 15:10The point here is that it's an exciting time and that we're all
- 15:13in agreement that we need to offer something better.
- 15:16And it's, there's not a national consensus on what that should
- 15:21be. And I, this might not be the
- 15:24best plan, but I don't think there has to be a single answer
- 15:28because it really should involve the woman's opinion on what is
- 15:32right for her. There are several options
- 15:35available, you know, if you qualify to have an MRI, if
- 15:38you're higher risk or your site, the place that you go to for
- 15:42medical care offers that for you.
- 15:44If your insurance covers it, maybe that's the right option
- 15:47for you. And there's contrast enhanced
- 15:49mammography that is growing and might be a good option for
- 15:52people. But in our current time in our
- 15:55practice, the MBI has been really useful because we see
- 15:59patients a lot who for lots of reasons they don't want to get
- 16:03into an MRI scanner. It's difficult for them to do
- 16:06that or they, you know, they have some other contraindication
- 16:10like they have a pacemaker or something.
- 16:12So I think it's really exciting that we have several options and
- 16:17it might just depend on, on more factors than than even the data,
- 16:21but the data for our modality is really strong.
- 16:24And I'm I'm glad that we have that in hand as well.
- 16:29You know, I love the I love that that it's not just one thing.
- 16:33And the researchers that we have funded along the way and the
- 16:38ones that I've interviewed is coming at it from multiple
- 16:42directions, is looking at proteins and it's looking at so
- 16:46many different aspects. And again, that's one thing is
- 16:51probably not going to be the end all be all, but at least
- 16:55they're, we're all looking now in really different directions,
- 16:59which I think is just just the way we need to be doing it.
- 17:03And you all y'all have really started to something that's very
- 17:08important. So excuse me.
- 17:10So I really appreciate, I appreciate what you've done.
- 17:14Are you encouraged about the processes?
- 17:17I, I am, I remain encouraged. I think there's been a real
- 17:21uptake in the number of people who want to do good research and
- 17:26want to have solid publications out there that, you know, these,
- 17:30this data. I know what it takes to put many
- 17:34years of work into designing a trial and bringing the right
- 17:37people together and the right analysis and then the peer
- 17:40review. I mean, it is a lot, but it's
- 17:44encouraging to me to see there are so many younger researchers
- 17:48that want to get into the field and want to do it right.
- 17:51Because if you, if you do a trial right, then it makes a
- 17:54real difference and it can affect someone's life.
- 17:57And you can use that data to maybe lobby for insurance
- 18:00coverage or whatever it takes to actually get that into practice
- 18:04or lobby for a a recommendation that'll be a more national
- 18:07recommendation. So I'm encouraged by that.
- 18:11I'm also excited because some of the work we're doing at Mayo
- 18:16Clinic is really focused on great translating that research
- 18:21into practice. So yes, we did this great trial.
- 18:23Great. What does that mean for people?
- 18:25Well, you know, if the cost of the test is going to be
- 18:29something that isn't reimbursed, then nobody's going to do it,
- 18:33you know, so we're doing a lot of sub analysis on that and
- 18:36trying to understand, you know, did it.
- 18:38Is it kind of like worth the cost to find those additional
- 18:41cancers? I think it will be.
- 18:43But we're in the process of that.
- 18:45We're also trying to to understand, well, we could offer
- 18:49this test, but if women don't want to do it, then it's not
- 18:52going to matter either. So we're trying to, you know, do
- 18:54a lot of patient engagement and understand like, what would you
- 18:58do differently? Would you?
- 19:00We did a, you know, a little survey last year.
- 19:02We're going to continue to solicit patient feedback to make
- 19:05improvements to the technology. And one of the things we're
- 19:08working on that's really exciting and it's kind of out of
- 19:11my depth, but I'm hiring the right person to do this, is to
- 19:15use AI tools to try to make the imaging faster so it'll then
- 19:20make it easier for the patient. So we're looking to the future
- 19:24to just continue to make improvements.
- 19:26And I love that the things we're working on, we can adapt to
- 19:29other modalities as well. So yeah, that's that's really
- 19:33our focus is to do good research and actually make it make a
- 19:38difference in someone's life. Well, I, I thank you so much for
- 19:43sharing all of your information and it's a joy to to have a
- 19:48chance to chat with you too. So thank you for being a part of
- 19:52this and we just really appreciate your work.
- 19:55Right. I just wanted to thank you,
- 19:57Martha, and your organization for offering the seed grants,
- 20:01but also making the seed grants so easy for researchers to apply
- 20:07for because I I'm not sure that everyone appreciates the
- 20:11intensity that it takes to apply for a federal grant or even a
- 20:16foundation grant. There's just a lot of paperwork.
- 20:19There's the grant itself, which takes many months to put
- 20:23together your ideas and write all the sections that they want.
- 20:27But then there's this whole other set of just paperwork and
- 20:30logistics. And it takes huge teams of
- 20:32people to to spend time doing all that.
- 20:36And then you're always so nervous because you could have
- 20:38missed just one form or one question on a form and they will
- 20:43toss your whole grant out. So the, the process, I'm just
- 20:47trying to convey that the process of applying for a grant
- 20:50is arduous and it's a, it's just a huge barrier to, it's another
- 20:55barrier to getting funding. So the seed grants are important
- 20:58for many reasons. I mean, the money is what is
- 21:01needed. The respect of obtaining your
- 21:04first grant is really important so that you can go for the next
- 21:07grant. But just I really always
- 21:09appreciated how simple it was to apply and I just felt like it
- 21:15was taken into good hands and I knew someone was actually going
- 21:18to read it and take an interest in it.
- 21:21It wasn't just put on the pile of 1000 others.
- 21:24So I just want to thank you for the process.
- 21:28Well, thank you for offering that.
- 21:30I really appreciate it. And that'll help our our donors
- 21:33to realize that our medical Advisory Board is doing a great
- 21:37job. So thank you so much, Karen.
- 21:40You're welcome. So how?
- 21:43Happy holidays, right? Thank you.
- 21:46Same to you, Martha. Thank you for everything you do.
- 21:49Thank you. We appreciate it.
- 21:50Thank you. Bye.
- 21:52Bye. This episode of Isn't That
- 21:55Interesting was made possible thanks to volunteers and donors
- 21:58just like you. It was hosted by Martha Kaley,
- 22:01founderofearlier.org and edited by Liam Mcburney.
- 22:06I'm Valerie Amsterdam, reminding you that for the last 30 years,
- 22:10this is North Carolina based organization has helped fund
- 22:13groundbreaking research all over the world, from molecular
- 22:16imaging to a sensitive blood test for breast cancer.
- 22:20Plain and simple, earlier detection saves lives.
- 22:23And you can help host a fundraising event, make a
- 22:26donation or volunteer your time. You can find us not only on the
- 22:30web, but on Facebook and Instagram too.
- 22:32Let's change the picture of breast cancer together.